Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.1% |
| 2 | Technology | 1.55% |
| 3 | Consumer Discretionary | 0.95% |
| 4 | Financials | 0.77% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Transmedics
TMDX
$3.07B
| $6.12M | ﹤0.01% |
91,004
-129,600
| -59% | -$8.91M |
|
3277
PUT
Impinj
PI
$5.2B
| $6.12M | ﹤0.01% |
67,500
-33,900
| -33% | -$3.8M |
|
3278
Insight Enterprises
NSIT
$4.57B
| $6.12M | ﹤0.01% |
40,814
+21,905
| +116% | +$3.53M |
|
3279
CALL
Vanguard Consumer Discretionary ETF
VCR
$6.04B
| $6.12M | ﹤0.01% |
18,800
+6,500
| +53% | +$2.35M |
|
|
PPL
3280
PPL Corp
PPL
$25.7B
| $6.12M | ﹤0.01% |
169,418
-150,811
| -47% | -$5.11M |
|
3281
PUT
HealthEquity
HQY
$7.97B
| $6.12M | ﹤0.01% |
69,200
+51,100
| +282% | +$5.24M |
|
3282
ADMA Biologics
ADMA
$2.09B
| $6.11M | ﹤0.01% |
308,191
+145,937
| +90% | +$2.52M |
|
3283
Matsons
MATX
$6.71B
| $6.11M | ﹤0.01% |
47,685
+26,461
| +125% | +$3.63M |
|
3284
CALL
Vornado Realty Trust
VNO
$7.13B
| $6.1M | ﹤0.01% |
164,900
-49,200
| -23% | -$1.98M |
|
3285
Krystal Biotech
KRYS
$10.4B
| $6.1M | ﹤0.01% |
33,829
-4,639
| -12% | -$780K |
|
3286
Vista Energy
VIST
$7.76B
| $6.07M | ﹤0.01% |
+130,450
| New | +$6.75M |
|
3287
PUT
RenaissanceRe
RNR
$13.7B
| $6.07M | ﹤0.01% |
25,300
-5,300
| -17% | -$1.28M |
|
3288
HubSpot
HUBS
$13B
| $6.07M | ﹤0.01% |
10,621
+9,286
| +696% | +$6.51M |
|
3289
CALL
IQVIA
IQV
$43.1B
| $6.06M | ﹤0.01% |
34,400
-35,400
| -51% | -$6.87M |
|
3290
DuPont de Nemours
DD
$18.5B
| $6.06M | ﹤0.01% |
64,692
-116,735
| -64% | -$11.4M |
|
3291
PUT
Brookfield
BN
$92.3B
| $6.06M | ﹤0.01% |
173,550
+33,000
| +23% | +$1.25M |
|
3292
CALL
Murphy USA
MUSA
$9.25B
| $6.06M | ﹤0.01% |
12,900
-10,100
| -44% | -$4.8M |
|
3293
PennyMac Financial
PFSI
$3.81B
| $6.06M | ﹤0.01% |
60,508
+1,152
| +2% | +$118K |
|
3294
Terex
TEX
$7.28B
| $6.06M | ﹤0.01% |
160,328
+89,838
| +127% | +$3.92M |
|
3295
Herbalife
HLF
$1.3B
| $6.05M | ﹤0.01% |
701,370
+657,740
| +1,508% | +$4.68M |
|
3296
CALL
Hippo Holdings
HIPO
$876M
| $6.05M | ﹤0.01% |
236,600
+128,000
| +118% | +$3.55M |
|
3297
Huron Consulting
HURN
$2.54B
| $6.05M | ﹤0.01% |
42,144
+20,545
| +95% | +$2.76M |
|
3298
Dillards
DDS
$9.69B
| $6.04M | ﹤0.01% |
16,878
+13,297
| +371% | +$5.72M |
|
3299
PUT
Mohawk Industries
MHK
$8.8B
| $6.04M | ﹤0.01% |
52,900
+23,900
| +82% | +$2.85M |
|
3300
dLocal
DLO
$4.42B
| $6.04M | ﹤0.01% |
724,188
-48,793
| -6% | -$550K |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q1 2025 filing shows 1,775 new, 5,712 increased, 4,842 reduced and 1,482 closed positions. Its largest new stake was Brookfield Asset Management: 1,775,684 shares worth $86M. The largest sale was Invesco QQQ Trust, an estimated $1.25B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.